Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Operations (2023 - 2025)

Upstream Bio (UPB) has 3 years of Cash from Operations data on record, last reported at 22240000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations fell 59.29% year-over-year to 22240000.0; the TTM value through Sep 2025 reached 122256000.0, down 119.61%, while the annual FY2024 figure was 59172000.0, 56.02% down from the prior year.
  • Cash from Operations reached 22240000.0 in Q3 2025 per UPB's latest filing, up from 39239000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8036000.0 in Q2 2024 and bottomed at 41165000.0 in Q1 2025.
  • Average Cash from Operations over 3 years is 22240750.0, with a median of 18587000.0 recorded in 2024.
  • Peak YoY movement for Cash from Operations: fell 21.74% in 2024, then plummeted 388.29% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 16110000.0 in 2023, then fell by 21.74% to 19612000.0 in 2024, then decreased by 13.4% to 22240000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 22240000.0 in Q3 2025, 39239000.0 in Q2 2025, and 41165000.0 in Q1 2025.